母亲产前对乙酰氨基酚处方与子代神经发育
这项基于台湾2004至2015年2 092 926例单胎出生的队列研究显示,全队列中母亲产前对乙酰氨基酚处方与子代ADHD和ASD存在关联,且在使用频率更高或平均日剂量更高时关联更明显;但同胞匹配分析中关联为零,双向分析呈现方向相反的关联,提示存在未解决的偏倚。
要点
- 全队列中产前对乙酰氨基酚处方与子代ADHD和ASD相关,高频或高剂量时关联更明显。
- 同胞匹配分析中产前对乙酰氨基酚暴露与子代ADHD和ASD的关联为零。
- 仅年长同胞暴露时呈正关联,仅年幼同胞暴露时呈负关联,提示偏倚未解决。
核心结论
- 全队列中母亲产前对乙酰氨基酚处方与子代ADHD或ASD呈正关联,但同胞匹配分析中未观察到关联。
- 同胞双向分析中关联方向明显分歧,提示存在未解决的偏倚,无法据此设计得出确切结论。
研究设计与样本
- 台湾2004至2015年2 092 926例单胎出生的队列研究,其中1 231 819例至少有一个同胞。
- 从全民健康保险研究数据库提取产前对乙酰氨基酚处方,定义为孕期至少2次配药记录,并分析处方总数和估计平均日配药剂量。
- 主要结局为从数据库确认的ADHD和ASD诊断,采用调整混杂因素的风险比(HR)及95%CI评估关联。
主要发现
- 2 092 926例单胎出生中,48.3%(n=1 012 159)的母亲孕期至少有过2次对乙酰氨基酚处方。
- ASD全队列(N=2 092 926)中23 557例(1.1%)患ASD;ADHD全队列(N=2 079 935)中116 387例(5.6%)患ADHD。
- 全队列中,子代ADHD和ASD与产前对乙酰氨基酚处方相关,使用频率更高或平均日配药剂量更高时也观察到关联。
- 同胞匹配分析中,产前对乙酰氨基酚暴露与子代ADHD和ASD的关联为零。
- 仅年长同胞暴露时呈正关联(ADHD HR 1.33 [95%CI 1.17-1.52];ASD HR 1.75 [95%CI 1.29-2.36]),仅年幼同胞暴露时呈负关联(ADHD HR 0.75 [95%CI 0.67-0.84];ASD HR 0.74 [95%CI 0.57-0.96])。
临床怎么用
- 儿科医生解读产前对乙酰氨基酚暴露与子代ADHD/ASD关联时,应知晓全队列关联在同胞匹配分析中未重现。
- 同胞双向分析关联方向分歧提示存在未测量偏倚,不能据此因果推断或改变产前镇痛用药建议。
局限性
- 同胞双向分析中关联方向明显分歧,提示存在未解决的偏倚来源。
- 作者指出同胞设计无法得出确切结论。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Whether maternal use of acetaminophen during pregnancy is associated with offspring's neurodevelopment remains debated. OBJECTIVE: To evaluate the associations of maternal prenatal prescriptions of acetaminophen with attention-deficit/hyperactivity disorder (ADHD) and autism spectrum disorders (ASDs) among offspring. DESIGN, SETTING, PARTICIPANTS: This cohort study analyzed 2 092 926 singleton births between 2004 and 2015 in Taiwan, with 1 231 819 having at least 1 sibling. Estimated hazard ratios (HRs) and 95% CIs were examined for offspring ADHD or ASDs according to prenatal acetaminophen prescriptions, adjusting for confounding factors. EXPOSURE: Prescriptions of acetaminophen were extracted from the National Health Insurance Research Database (NHIRD). Acetaminophen use was defined as having at least 2 dispense records during pregnancy, and the total number of prescriptions and the estimated mean daily dispensed dose were examined. MAIN OUTCOMES AND MEASURES: The primary outcome was ascertaining diagnoses of ADHD and ASDs from the NHIRD. RESULTS: Of the 2 092 926 singleton births between 2004 and 2015, 48.3% (n = 1 012 159) were born to mothers with at least 2 acetaminophen prescriptions during pregnancy. In the full cohort ASD dataset (N = 2 092 926), 23 557 children (1.1%) had ASD, and in the full ADHD dataset (N = 2 079 935), 116 387 children (5.6%) had ADHD. In the full cohort, offspring ADHD and ASDs were associated with prenatal prescriptions to acetaminophen, with associations noted for higher frequencies of acetaminophen use or higher mean daily dispensed doses of acetaminophen. In sibling-matched analyses, the associations between prenatal exposures to acetaminophen and ADHD and ASDs among offspring were null. However, a positive association was observed when only the older sibling was exposed (HR, 1.33 [95% CI, 1.17-1.52] for ADHD; HR, 1.75 [95% CI, 1.29-2.36] for ASDs), and a negative association was observed when only the younger sibling was exposed (HR, 0.75 [95% CI, 0.67-0.84] for ADHD; HR, 0.74 [95% CI, 0.57-0.96] for ASDs). The divergence of associations persisted in the bidirectional analyses of higher frequencies of acetaminophen use or higher mean daily doses of acetaminophen. CONCLUSIONS AND RELEVANCE: The findings of this cohort study in Taiwan suggest that positive associations were observed between maternal prenatal acetaminophen prescriptions and offspring's ADHD or ASDs in the full cohort but not in the sibling-matched analyses. A substantial divergence in associations in the sibling bidirectional analyses indicates unaddressed sources of bias and prevents firm conclusions from being drawn using the sibling design.
引用
- Lee PC, Chuang YH, Hu YH, et al. Maternal Acetaminophen Use and Child Neurodevelopment. JAMA Pediatr. 2026. PMID: 41801232. doi:10.1001/jamapediatrics.2026.0071
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。